Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl
Damodar Valley Corporation
KODERMA, JHARKHAND
Bid Publish Date
01-Nov-2024, 12:56 pm
Bid End Date
22-Nov-2024, 1:00 pm
EMD
₹6,00,000
Value
₹4,95,71,656
Progress
Quantity
1127650
Category
Title76
Bid Type
Two Packet Bid
All India Institute Of Medical Sciences (aiims) has released a public tender for Title1, Title2, Title3, Title4, Title5, Title6, Title7, Title8, Title9, Title10, Title11, Title12, Title13, Title14, Title15, Title16, Title17, Title18, Title19, Title20, Title21, Title22, Title23, Title24, Title25, Title26, Title27, Title28, Title29, Title30, Title31, Title32, Title33, Title34, Title35, Title36, Title37, Title38, Title39, Title40, Title41, Title42, Title43, Title44, Title45, Title46, Title47, Title48, Title49, Title50, Title51, Title52, Title53, Title54, Title55, Title56, Title57, Title58, Title59, Title60, Title61, Title62, Title63, Title64, Title65, Title66, Title67, Title68, Title69, Title70, Title71, Title72, Title73, Title74, Title75, Title76, Title77, Title78, Title79, Title80, Title81, Title82. Quantity: 1127650. Submission Deadline: 22-11-2024 13: 00: 00. Download documents and apply online.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Damodar Valley Corporation
KODERMA, JHARKHAND
National Security Guard (nsg)
GUNTUR, ANDHRA PRADESH
Joint Venture Of Cil, Ntpc, Iocl, Fcil & Hfcl
GORAKHPUR, UTTAR PRADESH
Indian Army
JABALPUR, MADHYA PRADESH
Indian Army
JABALPUR, MADHYA PRADESH
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Title1 | AMINO ACID 10% WITH ELECTROLYTE 500ML | 250 | pieces | [email protected] | 30 |
| 2 | Title2 | INJ ADENOSINE 6MG | 500 | pieces | [email protected] | 30 |
| 3 | Title3 | INJ ADRENALINE BP 1MG 1ML 1ML INJ | 18,500 | pieces | [email protected] | 30 |
| 4 | Title4 | INJ AMINOPHYLLINE 25MG | 1,000 | pieces | [email protected] | 30 |
| 5 | Title5 | INJ AMIODARONE 50MG ML 3ML VIAL | 750 | pieces | [email protected] | 30 |
| 6 | Title6 | INJ ATRACURIUM 25MG 2.5ML | 5,000 | pieces | [email protected] | 30 |
| 7 | Title7 | INJ ATROPINE 0.6MG | 15,000 | pieces | [email protected] | 30 |
| 8 | Title8 | INJ BUPIVAICAINE 0.5 | 2,500 | pieces | [email protected] | 30 |
| 9 | Title9 | INJ BUPIVAICAINE 0.5 HEAVY 5ML | 3,500 | pieces | [email protected] | 30 |
| 10 | Title10 | INJ CALCIUM GLUCONATE 10ML | 15,000 | pieces | [email protected] | 30 |
| 11 | Title11 | INJ DEXAMETHASON 2MG/ML | 20,000 | pieces | [email protected] | 30 |
| 12 | Title12 | INJ DIAZEPAM 5MG ML | 200 | pieces | [email protected] | 30 |
| 13 | Title13 | INJ DIGOXIN 0.25MG ML | 200 | pieces | [email protected] | 30 |
| 14 | Title14 | INJ DOBUTAMINE 50MG ML 5ML VIAL | 5,000 | pieces | [email protected] | 30 |
| 15 | Title15 | INJ DOPAMINE 40MG ML | 3,000 | pieces | [email protected] | 30 |
| 16 | Title16 | INJ ESMOLOL 10MG ML | 200 | pieces | [email protected] | 30 |
| 17 | Title17 | INJ ETOMIDATE 2MG ML 10ML VIAL | 250 | pieces | [email protected] | 30 |
| 18 | Title18 | INJ FLUCONAZOLE 2MG ML | 750 | pieces | [email protected] | 30 |
| 19 | Title19 | INJ FRUSEMIDE 10MG ML 4ML VIAL | 35,000 | pieces | [email protected] | 30 |
| 20 | Title20 | INJ GLYCOPYROLATE 5MG | 5,000 | pieces | [email protected] | 30 |
| 21 | Title21 | INJ HALOPERIDOL 5MG ML | 5,000 | pieces | [email protected] | 30 |
| 22 | Title22 | INJ HEPARIN 25000 IU/ML | 1,000 | pieces | [email protected] | 30 |
| 23 | Title23 | INJ HEPARIN LOW MOLECULAR WT 40MG ENOXAPARINE | 15,000 | pieces | [email protected] | 30 |
| 24 | Title24 | INJ HEPARIN LOW MOLECULAR WT 60MG ENOXAPARINE | 15,000 | pieces | [email protected] | 30 |
| 25 | Title25 | INJ HUMAN REGULAR INSULIN 40IU ML | 500 | pieces | [email protected] | 30 |
| 26 | Title26 | INJ HYDROCORTISONE 100MG | 25,000 | pieces | [email protected] | 30 |
| 27 | Title27 | INJ HYOSCINE BUTYLBROMIDE 20MG/ML 1MLVIAL | 8,000 | pieces | [email protected] | 30 |
| 28 | Title28 | INJ IMIPENEM 1gm CILASTIN 1gm | 1,000 | pieces | [email protected] | 30 |
| 29 | Title29 | INJ IRON SUCROSE 200MG 10ML | 8,000 | pieces | [email protected] | 30 |
| 30 | Title30 | INJ KETAMIN | 600 | pieces | [email protected] | 30 |
| 31 | Title31 | INJ LABETALOL 20MG | 6,000 | pieces | [email protected] | 30 |
| 32 | Title32 | INJ LEVETRIACETAM 100MG ML 5ML VIAL | 25,000 | pieces | [email protected] | 30 |
| 33 | Title33 | INJ LIGNOCAINE ADRENALLINE 1ratio200,000 30ML | 3,500 | pieces | [email protected] | 30 |
| 34 | Title34 | INJ LIGNOCAINE 2 | 6,000 | pieces | [email protected] | 30 |
| 35 | Title35 | INJ LIGNOCAINE 2 WITHOUT PRESERVATIVE | 400 | pieces | [email protected] | 30 |
| 36 | Title36 | INJ LIGNOCAINE 4 30ML VIAL | 250 | pieces | [email protected] | 30 |
| 37 | Title37 | INJ LORAZEPAM 2MG INJ | 15,000 | pieces | [email protected] | 30 |
| 38 | Title38 | INJ MAGNESIUM SULPHATE 50 | 3,500 | pieces | [email protected] | 30 |
| 39 | Title39 | INJ METHYLPREDNISOLONE 80MG 2ML | 600 | pieces | [email protected] | 30 |
| 40 | Title40 | INJ METOCLOPROMIDE 10MG 2ML AMP | 15,000 | pieces | [email protected] | 30 |
| 41 | Title41 | INJ MIDAZOLAM 1MG/ML 5ML | 10,000 | pieces | [email protected] | 30 |
| 42 | Title42 | INJ N-ACETYLCYSTIENE | 1,000 | pieces | [email protected] | 30 |
| 43 | Title43 | INJ NITROGLYCERIN 5MG ML | 1,500 | pieces | [email protected] | 30 |
| 44 | Title44 | INJ NORADRENALINE BITARTRATE 2ML INJ | 20,000 | pieces | [email protected] | 30 |
| 45 | Title45 | INJ OCTREOTIDE 100MG 1ML | 300 | pieces | [email protected] | 30 |
| 46 | Title46 | INJ ONDANSETRON 2MG ML | 120,000 | pieces | [email protected] | 30 |
| 47 | Title47 | INJ OXYTOCINE 5IU/ML | 13,000 | pieces | [email protected] | 30 |
| 48 | Title48 | INJ PANTOPRAZOLE 40MG INJ | 95,000 | pieces | [email protected] | 30 |
| 49 | Title49 | INJ PENTAZOCINE LACTATE 1ML | 600 | pieces | [email protected] | 30 |
| 50 | Title50 | INJ PHENIRAMINE 44.5MG/2ML | 5,500 | pieces | [email protected] | 30 |
| 51 | Title51 | INJ PHENOBARBITONE 200MG/ML | 800 | pieces | [email protected] | 30 |
| 52 | Title52 | INJ PHENYTOIN 2ML | 8,000 | pieces | [email protected] | 30 |
| 53 | Title53 | INJ PHYTOMENADIONE 0.5MG/ML | 3,500 | pieces | [email protected] | 30 |
| 54 | Title54 | INJ PHYTOMENADIONE 10MG/ML | 3,500 | pieces | [email protected] | 30 |
| 55 | Title55 | INJ POTASSIUM CHLORIDE 20MEQ | 15,000 | pieces | [email protected] | 30 |
| 56 | Title56 | INJ PROPOFOL 10MG/CC | 12,000 | pieces | [email protected] | 30 |
| 57 | Title57 | INJ RANITIDINE 150MG/ML | 5,000 | pieces | [email protected] | 30 |
| 58 | Title58 | INJ ROCURONIUM 10MG/ML | 500 | pieces | [email protected] | 30 |
| 59 | Title59 | INJ SODIUM BICARBONATE 7.5% W/V (10ML) | 5,000 | pieces | [email protected] | 30 |
| 60 | Title60 | INJ SODIUM VALPROATE 100MG/ML | 3,000 | pieces | [email protected] | 30 |
| 61 | Title61 | INJ TETANUS TOXOID 0.5ML | 15,000 | pieces | [email protected] | 30 |
| 62 | Title62 | INJ THIAMINE 100MG | 3,000 | pieces | [email protected] | 30 |
| 63 | Title63 | INJ THIOPENTONE SIDIUM 500MG | 200 | pieces | [email protected] | 30 |
| 64 | Title64 | INJ TRAMADOL 100MG | 35,000 | pieces | [email protected] | 30 |
| 65 | Title65 | INJ TRANEXAMIC ACID 500MG | 35,000 | pieces | [email protected] | 30 |
| 66 | Title66 | INJ VECURONIUM 10MG | 8,000 | pieces | [email protected] | 30 |
| 67 | Title67 | ISOLYTE-M | 2,000 | pieces | [email protected] | 30 |
| 68 | Title68 | IV FLUIDS DEXTROSE 10% 500ML | 2,000 | pieces | [email protected] | 30 |
| 69 | Title69 | IV FLUIDS DEXTROSE 25% 100ML | 6,000 | pieces | [email protected] | 30 |
| 70 | Title70 | IV FLUIDS DEXTROSE 5% 500ML | 5,000 | pieces | [email protected] | 30 |
| 71 | Title71 | IV FLUIDS DEXTROSE 50% 50ML | 200 | pieces | [email protected] | 30 |
| 72 | Title72 | IV FLUIDS DEXTROSE NORMAL SALINE 500ML | 100,000 | pieces | [email protected] | 30 |
| 73 | Title73 | IV FLUIDS HALF DEXTROSE NORMAL SALINE 500ML | 1,500 | pieces | [email protected] | 30 |
| 74 | Title74 | IV FLUIDS ISOLYTE-P 500ML | 2,000 | pieces | [email protected] | 30 |
| 75 | Title75 | IV FLUIDS NORMAL SALINE 3% 100ML | 9,000 | pieces | [email protected] | 30 |
| 76 | Title76 | IV FLUIDS NORMAL SALINE 0.45% 500ML | 2,500 | pieces | [email protected] | 30 |
| 77 | Title77 | IV FLUIDS NORMAL SALINE 0.9% 100ML | 95,000 | pieces | [email protected] | 30 |
| 78 | Title78 | IV FLUIDS NORMAL SALINE 0.9% 3000ML | 1,500 | pieces | [email protected] | 30 |
| 79 | Title79 | IV FLUIDS NORMAL SALINE 0.9% 500ML | 95,000 | pieces | [email protected] | 30 |
| 80 | Title80 | IV FLUIDS RINGER LACTATE 500ML | 75,000 | pieces | [email protected] | 30 |
| 81 | Title81 | MANNITOL 100ML | 25,000 | pieces | [email protected] | 30 |
| 82 | Title82 | TOAL PARENTRAL NUTRITION | 600 | pieces | [email protected] | 30 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
To participate in this tender, bidders must meet specific eligibility requirements including registration as a valid entity, compliance with experience criteria, and submission of necessary certificates. Additionally, bidders must provide details about their past performance and annual turnover to demonstrate their capability to fulfill the contract.
Bidders need to submit various certificates including an OEM authorization certificate, quality management certifications, and any other requested documents related to eligibility. The requirement may include documentation proving exemptions from experience or turnover criteria backed by supportive evidence.
The registration process involves filling an online application form through the designated portal. Upon submission, bidders must ensure they provide all necessary documents as outlined in the tender requirements to complete their registration successfully.
Documents submitted for the tender need to be in standard formats preferably PDF or DOCX as specified by Department of Health and Family Welfare. It's crucial for bidders to check for any specific format requirements mentioned in the detailed requirements document.
Technical specifications detail the quality standards and compliance expected from the drugs supplied, including adherence to safety norms and the specifications laid out in the BoQ. Bidder proposals must be in strict accordance with these standards to qualify for evaluation.
Bidders must comply with the quality standards that pertain to pharmaceutical products, including adherence to pharmacopoeia specifications and standards set by national health authorities. This ensures that all delivered products meet health safety regulations and efficacy standards.
Yes, bidders are required to meet a series of compliance requirements outlined in the tender documents. This includes regulatory approvals for the pharmaceutical products and adherence to the specified terms within the tender.
Testing criteria are established to verify compliance with quality and efficacy standards. Bidders must ensure that products are tested and certified according to recognized pharmaceutical testing methods prior to delivery.
The EMD amount for this tender is set at ₹600,000. It is a mandatory requirement for all bidders to ensure seriousness in their proposals and is typically refundable upon contract completion or in case of bid rejection.
Successful bidders will be required to submit a performance security that guarantees contract fulfillment. The amount and specifics regarding performance security will be outlined further in the procurement documentation.
Payment terms will be specified in the final contractual agreement but generally stipulate payment after successful delivery and evaluation of the supplied products against the outlined specifications.
Price evaluation will consider the total cost quoted by the bidder in alignment with the technical evaluation, ensuring that the most advantageous proposal is selected while maintaining compliance with all outlined standards.
Bidders must submit their proposals via the designated online portal. All documents should be uploaded in the specified formats per the guidelines provided in the tender documents.
While specific dates may vary, it’s essential for bidders to refer to the tender documents for precise information on timelines and ensure their proposals are submitted within the stipulated window.
The evaluation process will involve a detailed assessment of each submission based on technical compliance, financial proposals, and overall value, leading to the selection of the most suitable bids for contract awarding.
Bidders will receive notifications regarding their proposal status post-evaluation. Details about the selection results will be communicated through the official channels as outlined in the tender documentation.
Micro, Small, and Medium Enterprises will benefit from special provisions aimed at increasing their participation in government tenders. These may include relaxed eligibility criteria and financial aids to foster support for local businesses.
This tender includes accommodations for startups, allowing them to compete effectively. The provisions encourage innovation and entrepreneurship in the health sector by facilitating easier access to procurement processes.
The tender supports the 'Make in India' initiative by encouraging local manufacturing and suppliers for pharmaceutical products, promoting self-reliance and economic growth within the domestic industry.
Yes, the tender may include local content requirements, ensuring that a certain percentage of the supplied goods are produced or sourced from within the country to promote domestic manufacturing in alignment with national policy objectives.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS